Ganoderma Lucidum Polysaccharide Peptide attenuates post myocardial infarction fibrosis via down-regulating TGF-β1/SMAD and relieving oxidative stress

• Autori principali: Jia Meng (Autore), Ang Ma (Autore), Shun Zhang (Autore), Dongmei Lin (Autore), Shuqian Lin (Autore), Min Li (Autore), Hong Zhou (Autore), Baoxue Yang (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2022-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

The Ganoderma lucidum, a well-known Chinese traditional medicine, has been used to prevent and treat cardiovascular diseases. The purpose of this study was to determine whether Ganoderma lucidum polysaccharide peptide (GLPP) has therapeutic effect on cardiac fibrosis. Using both mouse myocardial inf...